PDCD1 and non-Hodgkin lymphoma: It should be noted that PD‐1 served as an independent pathological and molecular prognostic biomarker associated with adverse OS in patients with AR‐NHL, and was associated with PD‐1+ Tregs numbers in the peripheral blood.